FAP and neoplasm: However, the available evidence has shown that FAPI is not an entirely tumour-specific agent, possibly due to a fibrotic reaction and FAP activation in chronic inflammation, increased radiolabeled FAPI uptake has been demonstrated in non-malignant conditions in recent studies.